Black Rock Inc. Isoray, Inc. Transaction History

Black Rock Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	N/A	3,356,296 Added 73.95%	7,894,685 $5.45 Million
Q3 2023 Nov 13, 2023	SELL	N/A	-799,393 Reduced 14.98%	4,538,389 $3.13 Million
Q2 2023 Aug 11, 2023	BUY	$0.0 - $0.69 $0 - $230,079	333,449 Added 6.66%	5,337,782 $3.68 Million
Q1 2023 May 12, 2023	BUY	$0.0 - $0.67 $0 - $1.71 Million	2,546,765 Added 103.63%	5,004,333 $3.2 Million
Q4 2022 Feb 13, 2023	BUY	$0.24 - $0.4 $3,413 - $5,689	14,224 Added 0.58%	2,457,568 $589,000
Q3 2022 Nov 14, 2022	SELL	$0.22 - $0.43 $441 - $863	-2,009 Reduced 0.08%	2,443,344 $562,000
Q2 2022 Aug 12, 2022	BUY	$0.26 - $0.37 $1,595 - $2,269	6,135 Added 0.25%	2,445,353 $756,000
Q1 2022 May 12, 2022	BUY	$0.31 - $0.41 $292 - $387	945 Added 0.04%	2,439,218 $885,000
Q4 2021 Feb 10, 2022	SELL	$0.38 - $0.68 $9,318 - $16,674	-24,522 Reduced 1.0%	2,438,273 $945,000
Q3 2021 Nov 09, 2021	SELL	$0.58 - $0.79 $167 - $228	-289 Reduced 0.01%	2,462,795 $1.55 Million
Q2 2021 Aug 11, 2021	BUY	$0.75 - $1.15 $1.85 Million - $2.83 Million	2,463,084 New	2,463,084 $1.97 Million

287K

Ticker ISR
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 142,112,992
Market Cap $98.1M
Description
Isoray, Inc., through its subsidiary, IsoRay Medical, Inc., develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases in the United States and internationally. The company offers CS-1 Cesium-131 brachytherapy seeds for the treatment of prostate, brain, lung, head and nec...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.